SCHEMBL9220052

SCHEMBL9220052

CCOC(=O)c1ccc(OCC(C)C2CCN(c3ccc(Cl)nn3)CC2)cc1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.47
MEN1 O00255 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
LMNA P02545 2/20 0.45
HTT P42858 1/20 0.45
HRH3 Q9Y5N1 2/20 0.44
MAPT P10636 2/20 0.42
KDM4E B2RXH2 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
RXFP1 Q9HBX9 1/20 0.42
PANK3 Q9H999 5/20 0.40
PIK3CA P42336 1/20 0.40
FDFT1 P37268 1/20 0.39
KCNH2 Q12809 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
OGA O60502 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10588331 0.85 MEN1 (0.49) KMT2AMEN1SMN1; SMN2LMNAHTT
SCHEMBL10588330 0.85 MEN1 (0.49) KMT2AMEN1SMN1; SMN2LMNAHTT
SCHEMBL9218090 0.84 HRH3 (0.40) KMT2ALMNAHRH3MAPTKDM4E
SCHEMBL9220790 0.83 MEN1 (0.47) KMT2AMEN1SMN1; SMN2LMNAHTT
SCHEMBL9197768 0.79 HRH3 (0.53) KMT2AMEN1LMNAHRH3MAPT
SCHEMBL15004872 0.78 HRH3 (0.60) HRH3KCNH2
SCHEMBL9218533 0.78 KDM4E (0.43) KMT2AMEN1SMN1; SMN2LMNAHTT
SCHEMBL9219673 0.77 NPC1 (0.43) KMT2AMEN1SMN1; SMN2LMNAHTT
SCHEMBL9216214 0.76 GAA (0.46) KMT2AMEN1LMNAHRH3MAPT
SCHEMBL14191673 0.76 NR1I2 (0.48) LMNAHTTHRH3MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0320032-B1 Pyridizinamine derivatives JANSSEN PHARMACEUTICA NV (BE) 1995-01-18 EP disclosed
US-5231184-A Viricide intermediate JANSSEN PHARMACEUTICA N.V. (BE) 1993-07-27 US disclosed
CN-1021328-C PROCESS FOR PREPARING PYRIDAZINAMINE DERIVATIVES JANSSEN PHARMACEUTICA NV (BE) 1993-06-23 CN disclosed
US-5106973-A Viricide intermediates JANSSEN PHARMACEUTICA N.V. (BE) 1992-04-21 US disclosed
US-4992433-A Viricides JANSSEN PHARMACEUTICA N.V. (BE) 1991-02-12 US disclosed
EP-0320032-A1 Pyridizinamine derivatives JANSSEN PHARMACEUTICA N.V. (BE) 1989-06-14 EP disclosed
CN-1033274-A The preparation method of new Pyridazinyl amine derivative JANSSEN PHARMACEUTICA NV (BE) 1989-06-07 CN disclosed